In our model, BRG1 occurs at E2F/CpG-positive, highly acetylated promoters of genes that are overexpressed in breast primary tumor, and two selected highly invasive breast cancer cell lines: MCF7 and MDA-MB-231. This evidence concerns the gene SMARCA4 and breast cancer.